β-D-N4-Hydroxycytidine; EIDD-1931
3258-02-4
259.22
C9H13N3O6
DMF, DMSO, PBS (pH 7.2)
-20°C
N4-Hydroxycytidine was originally identified as a mutagen effecting AT to GC base-pair transitions . It has also been found to have antiviral properties against a broad range of viruses including hepatitis C, norovirus, Ebola virus, influenza and respiratory syncytial viruses and coronaviruses. Active molecule in the antiviral pro-drug clinical candidate EIDD-28017.
Antiviral drug effective against coronavirus.
0.1 lbs
Research or further manufacturing use only, not for food or drug use.
